Chlorite formulations, and methods of preparation and use thereof
AssigneeNeuraltus Pharmaceuticals, Inc.
InventorsWilliam Boulanger, Arasteh Ari Azhir
Life of this patent
Estimating the term…
Abstract
Described herein are chlorite formulations having a pH between about 7 and about 8.5, wherein the chlorite formulations are substantially free of deleterious non-chlorite components. Described herein are chlorite formulations, including pharmaceutical formulations, which are formulated for systemic, parenteral, or intravenous administration. Described herein are methods of preparing and methods of using the chlorite formulations described herein.
Claims16
A method of administering chlorite, wherein the method comprises parenterally administering to a subject in need thereof a therapeutically effective amount of an aqueous formulation comprising an aqueous solvent, a pH adjusting agent comprising phosphate, and chlorite, wherein said chlorite is purified to greater than about 95% chlorite ions to non-chlorite ions.
Dependencies are inferred from the claim text.